16 California research projects selected to receive inaugural seed grants from Cal-BRAIN Cal-BRAIN.

The proposals were examined by experts outside of California, to decrease the chance of conflicts of interest. They were first assessed by Cal-BRAIN’s out-of-state scientific advisory panel which then made recommendations on relevant subject experts, also out-of-state, to conduct detailed reviews. The review requirements included scientific quality, significance, scalability and innovation. The Cal-Human brain directors made the ultimate selections based on the reviews and also on relevance to the Cal-BRAIN mission. Related StoriesAmgen, Novartis collaborate for Alzheimer's disease and migraine programsAdvances in whole mount mind imaging: an interview with Patrick Myles, President, Huron Digital PathologyInner ear harm human brain warnings from nerve cellsCal-BRAIN comes with an initial budget allocation of $2 million.

Collaborating successfully with various other healthcare companies. Interviewing and assessing your individuals . Producing evidence-based scientific decisions. Using validated documentation practices to aid patient care. Developing and implementing treatment plans. ADAPT is an exciting, transformative, abilities building system for pharmacists, stated APhA Executive Vice President and CEO, Thomas E. Menighan, BSPharm. MBA, ScD , FAPhA. This program provides another device along pharmacists’ professional advancement continuum and a mechanism to gain recognition. The data, skills and performance features obtained by those completing this program can help them assume greater patient care functions as members of the healthcare group.Collaborating successfully with various other healthcare companies. Interviewing and assessing your individuals . Producing evidence-based scientific decisions. Using validated documentation practices to aid patient care. Developing and implementing treatment plans. ADAPT is an exciting, transformative, abilities building system for pharmacists, stated APhA Executive Vice President and CEO, Thomas E. Menighan, BSPharm. MBA, ScD , FAPhA. This program provides another device along pharmacists’ professional advancement continuum and a mechanism to gain recognition. The data, skills and performance features obtained by those completing this program can help them assume greater patient care functions as members of the healthcare group.